Nomura Securities Maintains a 'Neutral' on SPX Corp. (SPW); Thoughts on Acquisition of CLYDEUNION Pumps
Get Alerts SPW Hot Sheet
Price: $49.44 +2.25%
Rating Summary:
10 Buy, 10 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Rating Summary:
10 Buy, 10 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Join SI Premium – FREE
Nomura Securities maintains a 'Neutral' on SPX Corp. (NYSE: SPW) price target of $70.00.
Nomura analyst, Shannon O’Callaghan, said, "SPW announced it entered into an agreement with Clyde Blowers Capital to acquire CLYDEUNION pumps for ~$1.1B. This represents ~12x 2011E EBITDA and ~10.5x 2012E EBITDA. Management is guiding to $0.30-$0.40 of EPS accretion in 2012 ($0.60- $0.70 of cash EPS accretion) assuming organic sales growth of 10%+ and no synergies in 2012. The deal is expected to close in 4Q11. We continue to like SPX’s long-term earnings power but remain on the sidelines, given increased risk to 2H11/2012 and our view of a decreased sense of urgency to get into the stock."
For more ratings news on SPX Corp. click here and for the rating history of SPX Corp. click here.
Shares of SPX Corp. closed at $48.96 yesterday.
Nomura analyst, Shannon O’Callaghan, said, "SPW announced it entered into an agreement with Clyde Blowers Capital to acquire CLYDEUNION pumps for ~$1.1B. This represents ~12x 2011E EBITDA and ~10.5x 2012E EBITDA. Management is guiding to $0.30-$0.40 of EPS accretion in 2012 ($0.60- $0.70 of cash EPS accretion) assuming organic sales growth of 10%+ and no synergies in 2012. The deal is expected to close in 4Q11. We continue to like SPX’s long-term earnings power but remain on the sidelines, given increased risk to 2H11/2012 and our view of a decreased sense of urgency to get into the stock."
For more ratings news on SPX Corp. click here and for the rating history of SPX Corp. click here.
Shares of SPX Corp. closed at $48.96 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Axos Financial (AX) PT Raised to $120 at Benchmark
- Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Nomura, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share